Pliant Therapeutics
PLRX
$15.27
Share price
-2.18%
Change (1 day)
-29.08%
Change (1 year)
Categories
Operating Margin for Pliant Therapeutics (PLRX)
Operating Margin as of May 2024 (TTM): -1,285.93%
According to Pliant Therapeutics's latest financial reports and stock price the company's current Operating Margin is -1,285.93%. At the end of 2021 the company had an Operating Margin of -1,284.51%.
Operating Margin history for Pliant Therapeutics from 2020 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -1,284.51% | 1193.29% |
| 2020 | -99.32% | 8880.12% |
| 2019 | -1.11% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -36.36% | -97.17% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -8,391.15% | 552.54% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.